Editorial: High qHBsAg—Is it a good or bad signal? Authors' reply

Documenti analoghi

• Letter: No Biochemical Relapse Is Associated With the Highest Off‐Therapy HBsAg Loss Rate
  di: Wen‐Juei Jeng, et al.
  Pubblicazione: (2025)
• Letter: Dynamic HBcrAg and HBsAg After Nucleos(t)ide Analogue Cessation: Considerations in Interpreting Predictive Performance
  di: Hsiang‐Ting Keng, et al.
  Pubblicazione: (2026)
• Higher end‐of‐treatment HBsAg levels is associated with later onset but not severe relapse in HBeAg‐negative chronic hepatitis B patients stopping antivirals
  di: Yen‐Chun Liu, et al.
  Pubblicazione: (2024)
• Editorial: Recompensation in PBC is good. But is it good enough? Authors' reply
  di: Benedikt Silvester Hofer, et al.
  Pubblicazione: (2024)
• Editorial: Ultralow HBsAg Levels and the Prediction of Cure in Chronic Hepatitis B—Authors' Reply
  di: Jian Wang, et al.
  Pubblicazione: (2025)